$47.78 (0.0628%)

Volume: 282.59k

Closed: Jan 27, 2023

Hollow Logo Score: 1.207
Blueprint Medicines Corporation Stock
$47.78 (0.0628%)

Volume: 282.59k

Closed: Jan 27, 2023

Score Hollow Logo 1.207
NASDAQ:BPMC

Blueprint Medicines Corporation Stock Price (Quote)

$47.78 ( 0.0628% ) Friday, 27th Jan 2023

Range Low Price High Price Comment
30 days $41.72 $51.07 Friday, 27th Jan 2023 BPMC stock ended at $47.78. This is 0.0628% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 2.12% from a day low at $47.01 to a day high of $48.00.
90 days $40.78 $53.81
52 weeks $40.78 $85.67

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
2023-01-27 $47.23 $48.00 $47.01 $47.78 282 590
2023-01-26 $47.04 $47.83 $46.09 $47.75 369 763
2023-01-25 $47.68 $47.94 $46.02 $46.65 305 120
2023-01-24 $46.51 $47.99 $45.73 $47.97 413 570
2023-01-23 $46.58 $47.18 $45.11 $46.51 583 834
2023-01-20 $47.07 $47.35 $45.96 $46.69 421 800
2023-01-19 $46.56 $47.67 $45.03 $46.40 437 200
2023-01-18 $47.63 $48.72 $46.54 $46.65 633 900
2023-01-17 $47.58 $48.19 $46.54 $47.37 463 134
2023-01-13 $49.45 $51.07 $46.60 $47.85 717 900
2023-01-12 $46.82 $50.41 $46.45 $50.00 502 200
2023-01-11 $47.09 $47.96 $46.30 $46.82 616 916
2023-01-10 $45.80 $47.25 $45.73 $47.19 340 200
2023-01-09 $47.26 $47.42 $45.75 $45.78 371 344
2023-01-06 $46.41 $47.65 $44.81 $46.87 304 100
2023-01-05 $47.70 $48.00 $46.14 $47.01 561 285
2023-01-04 $43.69 $47.44 $43.69 $47.37 483 460
2023-01-03 $45.46 $45.47 $42.87 $43.30 478 804
2022-12-30 $42.38 $43.87 $41.95 $43.81 441 430
2022-12-29 $42.50 $43.97 $41.97 $43.00 529 992
2022-12-28 $41.85 $42.92 $41.72 $42.18 362 467
2022-12-27 $43.98 $43.99 $41.87 $41.92 299 031
2022-12-23 $44.46 $44.69 $43.10 $44.15 452 617
2022-12-22 $43.85 $44.93 $43.18 $44.60 453 461
2022-12-21 $44.17 $45.48 $43.85 $44.54 516 702
2022-12-20 $42.61 $44.57 $42.61 $43.79 474 111
2022-12-19 $44.72 $45.47 $42.33 $42.97 589 878
2022-12-16 $44.66 $45.77 $43.39 $45.22 1 616 260
2022-12-15 $45.99 $46.53 $44.53 $45.11 478 963
2022-12-14 $47.48 $48.20 $46.30 $46.73 444 622
2022-12-13 $46.67 $47.41 $45.18 $46.60 470 487
2022-12-12 $47.31 $47.31 $45.02 $45.42 659 939
2022-12-09 $46.59 $47.51 $46.38 $47.24 427 708
2022-12-08 $46.84 $47.11 $45.32 $46.78 568 667
2022-12-07 $48.11 $48.58 $46.68 $46.85 371 965
2022-12-06 $49.97 $50.11 $48.00 $48.51 510 685
2022-12-05 $48.55 $50.53 $47.50 $50.19 821 614
2022-12-02 $46.90 $49.04 $46.65 $48.93 651 513
2022-12-01 $47.79 $48.45 $47.30 $47.49 599 079
2022-11-30 $46.93 $47.93 $45.58 $47.79 614 313
2022-11-29 $45.38 $46.94 $45.38 $46.60 922 314
2022-11-28 $44.78 $45.81 $44.41 $45.23 614 656
2022-11-25 $44.32 $45.17 $44.15 $44.89 173 508
2022-11-23 $43.67 $46.15 $43.67 $44.83 697 168
2022-11-22 $43.24 $44.07 $42.31 $43.57 551 893
2022-11-21 $42.10 $43.19 $41.73 $42.99 448 531
2022-11-18 $43.34 $43.35 $41.93 $42.53 227 756
2022-11-17 $42.04 $42.71 $41.06 $42.17 213 524
2022-11-16 $43.46 $43.71 $42.37 $42.49 319 368
2022-11-15 $43.06 $43.89 $42.86 $43.52 249 134

Hot Stocks To Watch:

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT